Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - November 6, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregate
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-11-06 4:15 PM EST | Psyched Wellness Ltd.
Digicann Ventures Signs Definitive Share Exchange Agreement with Winning Asia Technology Macau Limited for Proposed Reverse Takeover Transaction
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2026) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company") is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4, 2026, with Winning Asia Technology Macau Limited ("WAT") and its shareholders, pursuant to which Digicann proposes to acquire all o
Services bancaires / financiers, Cannabis
2026-11-05 2:52 PM EST | Digicann Ventures Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial
Toronto, Ontario--(Newsfile Corp. - November 3, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Healt
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-11-03 8:02 AM EST | Rhelion Life Sciences Corp.
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Vancouver, British Columbia--(Newsfil
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-11-03 6:30 AM EST | VEXT Science, Inc.
Herbal Dispatch Accelerates Veteran Program Growth and Expands Access with New Clinic Partnership
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis commerce and international distribution platform, today issued a progress report on Hero Dispatch (herodispatch.com), the Company's medical cannabis program for Canadian Veterans, and highlighted the continued expansion o
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-11-03 5:00 AM EST | Herbal Dispatch Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing
Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-11-02 7:37 AM EST | Rhelion Life Sciences Corp.
MustGrow Appoints Kevin Helash as Chief Executive Officer
Saskatoon, Saskatchewan--(Newsfile Corp. - November 2, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, today announced the appointment of Kevin Helash as Chief Executive Officer, effective November 1, 2026. Mr. Helash brings extensive international leadership experience in the agricultural industry. He previously served as CEO of Biotalys, Marrone
Agriculture, Biotechnologies, Cannabis, Sélectionneurs de cannabis
2026-11-02 7:00 AM EST | MustGrow Biologics Corp.
CBD of Denver Outlines Growth Strategy for BioCannabis, Its Integrated European CBD and CBG Production Platform
Nea Apollonia, Greece--(Newsfile Corp. - October 29, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBD of Denver" or the "Company") today outlined the strategic priorities for BioCannabis, its operating business in Northern Greece, following the commercial relaunch of the business. Established Platform for Growth Through BioCannabis, CBD of Denver operates an integrated CBD and CBG production platform combining cultivation, processing and extraction within a single ope
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-29 8:30 AM EDT | CBD of Denver Inc.
Vext Secures Eighth Ohio Dispensary Location, Reaching the State Maximum
Secures provisional dual-use license for an eighth Ohio dispensary, in Amelia, targeted to open by the end of Q3 2027, subject to regulatory approvals Brings Vext to eight, the most Ohio allows a single operator; with the second Columbus store opening in Q1 2027, all eight are expected to be open in 2027 Full build-out puts more volume through Vext's own Jackson cultivation and manufacturing, which is expect
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-10-29 7:00 AM EDT | VEXT Science, Inc.
Vext Announces Date for Q3 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that the Company expects to release its financial results for the period ended September 30, 2026, before market open on Tuesday, November 3, 2026. The Company will host
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-10-29 6:30 AM EDT | VEXT Science, Inc.
Delivra Health Brands Reports FY2026 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer-packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the 12 months ended June 30, 2026 ("fiscal 2026"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-28 5:53 PM EDT | Delivra Health Brands Inc.
Charlotte's Web to Report Third Quarter 2026 Results on November 12
Louisville, Colorado--(Newsfile Corp. - October 28, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and market leader in cannabidiol (CBD) hemp extract wellness products, will report its 2026 third quarter financial results before market open on November 12, 2026, and will file its Quarterly Report on Form 10-Q the same da
2026-10-28 9:14 AM EDT | Charlotte's Web Holdings, Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder
Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Fil
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-10-28 8:00 AM EDT | Rhelion Life Sciences Corp.
Herbal Dispatch Announces Results of Its 2026 Annual General and Special Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - October 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to announce the results of its annual general and special meeting of shareholders (the "Meeting") held on Monday, October 26, 2026. All matters put before the Meeting were approved by the requisite majority. Shareholders fixed the number of directors at three and elected Philip
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-10-27 6:00 AM EDT | Herbal Dispatch Inc.
CBD of Denver, Inc. Announces Operating Business Relaunch Following BioCannabis Agreement and New International Supply Contracts
Nea Apollonia, Greece--(Newsfile Corp. - October 26, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced continued progress in the relaunch and expansion of the operating business of BioCannabis M. IKE ("BioCannabis"), a Greece-based vertically integrated hemp and cannabinoid company with established business-to-business ("B2B") wholesale operations and an expanding network of commercial customers. CBDD entered into a definitive Share Exchange Agre
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-26 8:30 AM EDT | CBD of Denver Inc.
MustGrow Announces "Fireside Chat" Webcast with Bayer AG
Saskatoon, Saskatchewan--(Newsfile Corp. - October 26, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") announces an upcoming webcast panel discussion with Bayer AG (BAYN) ("Bayer") featuring MustGrow's Chief Operating Officer Colin Bletsky with Ralf Glaubitz, Head of Crop Protection Product Team Biologicals at Bayer's Crop Science division. The "fireside chat" panel discussion will be broadcasted
Agriculture, Biotechnologies, Cannabis, Sélectionneurs de cannabis
2026-10-26 7:00 AM EDT | MustGrow Biologics Corp.
Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson & Company as Auditor
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) ("GHG" or the "Company") is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry. Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to priv
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Cannabis
2026-10-23 9:59 AM EDT | Global Hemp Group Inc.
City View Investee ArkenYield Signs MOU with Canadian Group Benefits Provider for Proposed $50 Million Yield Infrastructure Arrangement
Toronto, Ontario--(Newsfile Corp. - October 21, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that its investee company, ArkenYield Ltd. ("ArkenYield"), a provider of stablecoin liquidity and yield infrastructure, has entered into a non-binding Memorandum of Understanding ("MOU") with a Canadian group life and health benefits services provider to explore the integration of stablecoin-based yield solutions
Aliments / boissons, Cannabis, Extracteurs de cannabis, Producteurs de cannabis
2026-10-21 6:30 AM EDT | City View Green Holdings Inc.
Herbal Dispatch Expands Offering with New Ontario and Saskatchewan Listings and Increased BC Portfolio
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis commerce and international distribution platform, today announced that four of its Happy Hour SKUs have been listed with the Ontario Cannabis Store ("OCS"). The Company also provided an update on its British Columbia and Saskatchewan distribution. ONTARIO LISTINGS
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-10-20 6:00 AM EDT | Herbal Dispatch Inc.
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications. "We are witnessing a new era in the history of medicine: an era in which hum
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-10-19 7:00 AM EDT | Cannabis Bioscience International Holdings